Singapore markets closed

Syros Pharmaceuticals, Inc. (SYRS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.10+0.10 (+2.00%)
At close: 04:00PM EDT
5.05 -0.05 (-0.98%)
After hours: 04:05PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
139,526
167,467
92,302
173,984
-
Other short-term investments
0
34,837
38,067
0
-
Total cash
139,526
202,304
130,369
173,984
-
Net receivables
-
-
0
7
20,000
Other current assets
5,454
7,394
3,237
2,242
-
Total current assets
144,980
211,392
136,585
178,557
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
27,117
37,215
37,141
36,857
-
Accumulated depreciation
-7,634
-12,555
-9,856
-7,216
-
Net property, plant and equipment
19,483
24,660
27,285
29,641
-
Equity and other investments
-
0
13,038
0
-
Other long-term assets
3,711
8,434
6,027
5,052
-
Total non-current assets
23,194
33,094
46,350
34,693
-
Total assets
168,174
244,486
182,935
213,250
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
6,667
-
-
-
-
Accounts payable
11,544
6,411
3,692
3,603
-
Accrued liabilities
9,153
9,437
9,280
5,369
-
Deferred revenues
0
4,330
10,181
12,209
-
Total current liabilities
36,681
30,778
31,508
28,624
-
Non-current liabilities
Long-term debt
34,556
40,649
40,257
39,551
-
Deferred revenues
-
-
0
9,877
22,639
Other long-term liabilities
61,747
24,472
3,029
19,711
-
Total non-current liabilities
114,831
85,972
66,209
94,073
-
Total liabilities
151,512
116,750
97,717
122,697
-
Stockholders' equity
Common stock
26
20
6
56
-
Retained earnings
-722,807
-558,233
-463,579
-377,021
-
Accumulated other comprehensive income
0
102
-79
0
-
Total stockholders' equity
16,662
127,736
85,218
90,553
-
Total liabilities and stockholders' equity
168,174
244,486
182,935
213,250
-